98 related articles for article (PubMed ID: 94991)
1. Immunobiologic studies in hepatoma-bearing mice passively immunized to alpha-fetoprotein.
Mizejewski GJ; Dillon WR
Arch Immunol Ther Exp (Warsz); 1979; 27(5):655-62. PubMed ID: 94991
[TBL] [Abstract][Full Text] [Related]
2. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
3. Effect of anti-alpha-fetoprotein serum on growth and plating efficiency of alpha-fetoprotein-producing hepatoma cells in vitro.
Nishina K; Tsutamune T; Tokiwa T; Miyazaki M; Sato J
Acta Med Okayama; 1975 Aug; 29(4):319-26. PubMed ID: 55059
[TBL] [Abstract][Full Text] [Related]
4. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.
Gelin J; Moldawer LL; Lönnroth C; Sherry B; Chizzonite R; Lundholm K
Cancer Res; 1991 Jan; 51(1):415-21. PubMed ID: 1703040
[TBL] [Abstract][Full Text] [Related]
5. Modulation of tumor incidence by oncofetal products in a syngeneic hepatoma cell-spleen cell model.
Mizejewski GJ; Macario AL
Neoplasma; 1983; 30(1):23-34. PubMed ID: 6188067
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen and alpha-fetoprotein expression and monoclonal antibody targeting in a human hepatoma/nude mouse model.
Wang ZF; Stein R; Sharkey RM; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):869s-872s. PubMed ID: 1688735
[TBL] [Abstract][Full Text] [Related]
7. [Immunization with dendritic cells infected with human AFP adenovirus vector effectively elicits immunity against mouse hepatocellular carcinomas].
Tan XH; Zhu Q; Liu C; Liu XL; Shao XT; Wei B
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):13-6. PubMed ID: 16737612
[TBL] [Abstract][Full Text] [Related]
8. Effect of anti-alpha1-fetoprotein on alpha1-fetoprotein-producing rat tumors in vivo and in vitro.
Sell S; Sheppard HW; Nickel R; Stillman D; Michaelsen M
Cancer Res; 1976 Feb; 36(2 Pt 1):476-80. PubMed ID: 56992
[TBL] [Abstract][Full Text] [Related]
9. Conjugates of mitomycin with anti-alpha-fetoprotein antibody: antitumor effect against alpha-fetoprotein-producing human gastric carcinoma implanted in nude mice.
Takahashi Y; Mai M; Umemoto N; Kato Y; Hara T; Tsukada Y
NCI Monogr; 1987; (3):101-5. PubMed ID: 2434869
[TBL] [Abstract][Full Text] [Related]
10. Species cross-reaction of alpha-fetoproteins and break-down of the tolerance to alpha-fetoprotein by immunization with heterologous alpha-fetoprotein.
Nishi S; Watabe H; Hirai H
Tumor Res; 1973; 8():17-22. PubMed ID: 12308021
[TBL] [Abstract][Full Text] [Related]
11. [Humoral and cellular factors of immunity in mice with hepatoma 22A].
Kiseleva EP; Kositskaia LS; Ogurtsov RP
Vopr Onkol; 1988; 34(5):587-92. PubMed ID: 3289261
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of estrogen-sensitive rat mammary tumors. Effect of an alpha-fetoprotein-secreting hepatoma.
Sonnenschein C; Ucci AA; Soto AM
J Natl Cancer Inst; 1980 May; 64(5):1147-52. PubMed ID: 6154169
[TBL] [Abstract][Full Text] [Related]
14. Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.
Vollmer CM; Eilber FC; Butterfield LH; Ribas A; Dissette VB; Koh A; Montejo LD; Lee MC; Andrews KJ; McBride WH; Glaspy JA; Economou JS
Cancer Res; 1999 Jul; 59(13):3064-7. PubMed ID: 10397245
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor effects of paeonol in a HepA-hepatoma bearing mouse model via induction of tumor cell apoptosis and stimulation of IL-2 and TNF-alpha production.
Sun GP; Wang H; Xu SP; Shen YX; Wu Q; Chen ZD; Wei W
Eur J Pharmacol; 2008 Apr; 584(2-3):246-52. PubMed ID: 18329639
[TBL] [Abstract][Full Text] [Related]
17. Growth suppression of the hepatocellular carcinoma cell line Hepa1-6 by an activatable interferon regulatory factor-1 in mice.
Kröger A; Ortmann D; Krohne TU; Mohr L; Blum HE; Hauser H; Geissler M
Cancer Res; 2001 Mar; 61(6):2609-17. PubMed ID: 11289138
[TBL] [Abstract][Full Text] [Related]
18. [Effect of anti-human alpha-fetoprotein serum on human endodermal sinus tumor transplanted in nude mice (author's transl)].
Ohkawa K; Koike K; Amasaki H; Tohtake T; Terashima Y; Tsukada Y; Hara A; Hirai H
Acta Obstet Gynaecol Jpn; 1980 Dec; 32(12):1995-8. PubMed ID: 6163304
[TBL] [Abstract][Full Text] [Related]
19. Alpha fetoprotein: effect of heterologous antiserum on hepatoma cells in vitro.
Mizejewski GJ; Young SR; Allen RP
J Natl Cancer Inst; 1975 Jun; 54(6):1361-7. PubMed ID: 48552
[TBL] [Abstract][Full Text] [Related]
20. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
